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Objective: To determine the natural history of flare-ups in knee osteoarthritis and their relation to
physical exposures.
Design: Adults aged 45 years with a recent primary care consultation for knee OA/arthralgia completed
a daily pen-and-paper diary for up to three months, including questions on average knee pain intensity,
pain descriptors, other symptoms, activity interference, and selected physical exposures (prolonged
kneeling, squatting, climbing stairs, ladders, and moving/lifting heavy objects). Informed by a systematic
review, flare-ups were defined a priori. We calculated the rate of flare-ups in the sample, described their
nature and duration, and estimated their association with physical exposures in the prior 48 h.
Results: 67 participants completed at least one month of diaries, 37 (55%) were female, mean age 62
years (SD 10.6) with a mean body mass index of 24.6 kg/m2 (SD 5.1). 30 participants experienced a total
of 54 flare-ups (incidence density 1.12 (95%CI 0.80, 1.57) flare-ups/person-days). The median duration of
flare-ups was eight days (range: 2e30). During a flare-up participants were more likely to report sharp,
throbbing, stabbing, burning pain, swelling, limping, stiffness, being woken by pain, taking more anal-
gesia, and stopping usual activities. Exposure to one or more physical exposure increased the risk of a
flare-up in the subsequent 48 h (odds ratio 2.19 (95%CI: 1.22, 4.05)).
Conclusions: Our study with intensive longitudinal data collection suggests acute flare-ups may be
experienced by a substantial number of patients. These episodes often last a week or longer, are
disruptive, prompt changes in self-management, and may be triggered by high-loading physical
activities.
© 2019 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Longitudinal studies following patients with symptomatic knee
osteoarthritis over several years suggest that non-progressive
symptom trajectories are relatively common1. However, within
these average long-term trajectories, it is well-recognised that
patients can experience substantial variability in the presence,
nature, and severity of symptoms over time, including episodes ofE. Parry, Primary Care Centre
re & Health Sciences, Keele
uben.ogollah@nottingham.ac.
ternational. Published by Elsevier Lincreased pain that may be experienced as acute events2,3. These
events, particularly when they have an unpredictable, sudden
onset, can be distressing for patients and can impact on quality of
life, normal activities (including productivity losses4) and health
service use. Yet unlike other long-term conditions, there is still
considerable uncertainty around the nature, definitions, and ter-
minology of these phenomena in osteoarthritis. Classification
criteria for flare-ups in knee OA have been proposed but have not
been widely adopted5. Achieving greater clarity and agreement
on these matters is an important goal for research and clinical
communities6, toward which observational research can contribute
by gaining insight into the natural history of these phenomena,
possible triggers7, and other proximal and more distal
determinants.td. All rights reserved.
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OA in a sample of community-dwelling symptomatic adults, using
an observational daily diary study. We chose the term ‘flare-up’
over terms such as ‘exacerbation’ following workshops with
patients and members of the public on their preferred terminology
and from more frequently used terminology in the medical litera-
ture as found in a recent systematic review6
Method
Study design and sample
Adults aged 45 years and over registered at one of two General
Practices in the West Midlands, England and with a recorded
consultation for knee osteoarthritis or knee pain/arthralgia in the
previous two years were mailed a short questionnaire containing
items used to describe the sample, judge eligibility for the daily
diary study, and provide baseline values of ‘what is normal for me’
with respect to knee symptoms, activity, and analgesia (adapted
from Trappenburg et al.8). A standard three-stage mailing proced-
ure was used with non-respondents sent a reminder postcard at
two weeks and repeat questionnaire at four weeks. Respondents
were eligible for inclusion in the daily diary study if they reported
knee symptoms on at least one day in the previous 12 months,
provided written informed consent to further contact and indicated
their willingness to complete daily diaries for up to three months.
Respondents were excluded if they self-reported a diagnosis of
inflammatory disease, previous bilateral total knee replacement
(TKR) or TKR in the index knee (the worst affected knee) or did not
complete baseline knee symptom questions.
Data collection
All eligible, consenting questionnaire respondents were invited
to complete three consecutive one-month pen-and-paper diaries.
The diaries contained nine items for each day (see Supplementary
Data 1) which participants were asked to fill out at the end of the
day. Average pain intensity in the previous 24 h was assessed using
a 0e10 numerical rating scale (NRS)9.We included four single items
on other symptoms shown by Marty et al.5 to be associated with
OA flare-ups: stiffness lasting >20 min, swelling, night pain and
limping. Participants were also asked about pain quality using a
short list of descriptors which included continuous pain descriptors
(dull, aching, throbbing), intermittent pain descriptors (sharp,
stabbing), and neuropathic-type pain descriptors (burning, numb-
ness, pins and needles)3,10. Participants were asked if they had
undertaken any of a selected list of physical activities which have
previously been linked to onset of knee OA11. Participants were also
asked about any changes in usual medication (more than normal,
less than normal, the same) and whether symptoms had stopped
them taking part in usual activities.
The study was approved by the North of Scotland Research
Ethics Committee (Reference: 13/NS/0049).
Statistical analysis
Scatterplots were used to visually inspect daily pain intensity
scores for each participant. To estimate within-person variability
we calculated a Variability Index12 for each participant based on the
average standard deviation of their daily pain intensity scores
within half-monthly periods. The periods ranged from 14 to 16 days
due to the varying length of the month over the 3 month study
period. The standard deviation was chosen as it is the most com-
mon measure of variability which averages the absolute deviation
of each day's pain intensity from the mean pain over the 14e16days period thus capturing any pain fluctuations. This method has
also been used in a previous study investigating pain variability of
patients with fibromyalgia12. The 14e16 day periods were chosen
based on the number of available data points and to allow for
reliable estimation of SD due to the distribution assumptions. The
possible values were positive, with zero indicating no variability
and a higher number indicating greater variability. Informed by a
systematic review of flare-up definitions in the medical literature6,
and considering flare-up definitions used in other conditions13 we
defined a flare-up a priori as: an increase of at least two points from
baseline (‘normal for me’) in average pain intensity in the past 24 h
(0e10 NRS) which was sustained for at least two consecutive days.
A flare-up was judged to be resolved when pain intensity returned
to baseline level for five consecutive days.
We then estimated the proportion of respondents experiencing
at least one flare-up during the period of observation, the incidence
density with 95%CI of flare-ups for the sample as awhole (expressed
as the number of flare-ups per 100 person-days at risk, i.e., de-
nominator excluded days in flare-up and the five days needed for it
to be judged ‘resolved’) using Poisson regression taking into account
recurrent events, and the duration of flare-ups (median, inter-
quartile range (IQR)).
The time course of an ‘average’ flare-up was illustrated by
plotting combined group-mean daily pain intensity NRS scores
across all first flare-ups, anchored to a common timescale with zero
representing the first day of flare-up and extending to seven days
prior and 30 days after the flare-up. To describe the nature of flare-
ups and their impact on individuals, descriptive statistics (means,
SD or proportions) were used to summarise symptoms, change in
medication andwhether pain had stopped usual activities across all
flare-up days and all non-flare-up days, among participants expe-
riencing at least one flare-up. We then used mixed-effect models to
estimate the relative frequency (expressed as odds ratios) and
severity (expressed as regression coefficients) of symptoms on
flare-up vs non-flare-up days accounting for the clustered nature of
the observations.
To determine whether exposure to selected physical activities
was associated with flare-up onset, we conducted a case-crossover
analysis with each individual acting as their own control14. Case
windows for exposures were defined as the 48 h prior to the first
day of a flare-up. For each case we selected up to four matched
ambidirectional control windows which were 48-h periods on at-
risk days which corresponded with the same days of the week as
the case window to remove confounding by variation in physical
exposures across days of the week (e.g., weekdays vs weekends).
We calculated unadjusted exposure odds ratios (OR) based on the
conditional maximum likelihood estimate with 95% mid-P exact
confidence intervals using OpenEpi (www.OpenEpi.com).
Analyses were performed using Stata, Version 13 (StataCorp
2013).
Results
Of the 220 out of 330 responders to the baseline questionnaire,
106 (48%) were eligible and were invited to take part in the diary
study, consented to further contact, and were mailed the first diary.
Reasons for non-eligibility included; inflammatory disease (41),
TKR (27), missing/blank Q (22), no recent knee pain (14), withdrew/
died/moved (10). Of the 67 (63%) participants who completed at
least one monthly diary, 37 (55%) were female, mean age 62 years
(SD 10.6) with a mean body mass index of 24.6 kg/m2 (SD 5.1). Of a
possible 5,491 diary days, 4,328 (79%) were fully completed, 1,163
(21%) were partially completed, and 111 (2%) were missed
completely. Comparing responders to non-responders ages were
similar (mean age 62.2 (SD 10.6) and 61.7 (SD 11.0) respectively)
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(25 (64.1%) non-responders vs 37 (55.2%)).
The median Variability Index across the sample was 0.68
(IQR 0.41, 1.05), and this was higher during non-flare-up days in
participants classed as having experienced a flare-up than in those
participants who did not experience a flare-up ((median (IQR)):
0.83 (0.51, 1.13) vs 0.52 (0.27, 0.97).
Over the period of observation 30 participants (45%) were
classed as having experienced a total of 54 flare-ups (one flare-up
(n ¼ 16), two flare-ups (n ¼ 6), three flare-ups (n ¼ 6), four flare-
ups (n ¼ 2)) giving an estimated incidence density of 1.12 (95%CI
0.80, 1.57) flare-ups per 100 person-days. Illustrative examples of
participants with contrasting variability in daily pain scores are
provided in Supplementary Data 2.
Those experiencing a flare-up were slightly more likely to be
male (50% vs 40%; proportion difference (95% CI): 10% (14%, 33%)),
have a higher BMI (mean (SD) 25.5 (5) vs 23.9 (6) kg/m2; mean
difference (95% CI): 1.6 (0.9, 4.1)), and report previous injury (50%
vs 42%; proportion difference (95% CI): 8% (15%, 33%)), although
none of these differences were statistically significant given the
relatively small numbers of participants in each group.
The median duration for a flare-up was eight days (IQR 3, 23;
range 2e30). The ‘average’ time course shows the sudden onset and
relatively quick reduction in pain intensity within 48 h followed by
a longish plateau (Fig. 1). Flare-up days compared to non-flare-up
days were accompanied by a higher occurrence of knee stiffness
(OR 10.9; 95% CI: 7.0, 17.1), limping (12.4; 7.4, 20.8), swelling (14.5;
8.3, 25.4), being woken by pain (7.0; 4.3, 11.2), use of most pain
descriptors (but particularly ‘throbbing’, ‘sharp’, ‘stabbing’ pain,
and ‘numbness’), interference with usual activities (26.5; 3.7, 51.5)
and taking moremedication than normal (23.9; 13.8, 41.4) (Table I).
The above features tended to be at their highest levels during the
first two days of a flare-up (data not shown).
For the case-crossover analysis using physical exposures there
were 88 cases periods in total and 328 control periods. The number
of control periods per case ranged from 1 to 4 (median:2, mean:
2.43 (SD1.12)). Exposure to one or more of the selected physical
exposures (prolonged kneeling, lifting/moving heavy objects,Fig. 1. Time course of an ‘average’ flare from 7 days prior to 30 days after the onset of a flareclimbing several flights of stairs, prolonged squatting,
climbing ladders) was associated with increased risk of acute flare-
up in the subsequent 48 h (odds ratio 2.19; 95%CI: 1.22, 4.05)
(Supplementary Data 3). Exposure to each individual physical ac-
tivity was positively associated with flare-up onset but estimates
lacked precision due to small numbers of discordant pairs.
Discussion
Our study supports the notion that knee OA, for some people, is
characterised by intermittent acute or sudden increases in pain
with an associated change in pain quality and knee symptoms.
Pain intensity in our study was highly variable for some and
stable for others. Although not explored in this study, Schneider
et al. found a link between pain variability in OA and depression15.
Qualitative studies have highlighted the highly variable nature of
pain in OA2 and when unpredictable can be associated with
considerable distress3.
Predictability of pain is important for episode management and
patient understanding. Prior to flare-up onset we saw a marked
step up in symptoms rather than a gradual onset. This may be partly
due to once daily measurement, however, we found that certain
activities reported in the 48-h period prior to a flare-up were
associated with flare-up onset. Zobel et al. identified that knee
buckling and knee injury were triggers for acute events7. Physical
activity exposures have previously been associated with long term
incidence of osteoarthritis11. The link we have found may give an
insight into short term events and their intrinsic part in how OA
develops and progresses. It is possible that these acute events lead
to a cumulative insult on the knee joint that eventually leads to
disability.
Identifying potential triggers are important in the management
of flare-ups in terms of activity avoidance and for earlier and pre-
ventative management strategies. Other management strategies
that may lead to early termination of a flare-up include recognising
the early changes in symptoms, for example knee stiffness,
swelling, limping and night pain which have previously been used
as part of the criteria for flare-up identification5.(day 0). Points are group-mean pain intensity for all participants' first flares combined.
Table I





Relative frequency/severity on flare-up
days vs non-flare-up daysz
Average knee pain intensity (0-10NRS):
mean (SD)
5.4 (1.9) 3.1 (2.0) 2.5 (2.3, 2.6)
Pain descriptors
Dull 52 (17) 673 (35) 0.4 (0.2, 0.7)
Aching 218 (73) 1122 (59) 6.9 (4.1, 11.6)
Throbbing 95 (32) 301 (16) 18.1 (9.8, 33.3)
Sharp 146 (49) 206 (11) 11.2 (6.8, 18.6)
Stabbing 108 (36) 269 (14) 11.8 (7.2, 19.5)
Burning 73 (24) 171 (9) 6.7 (4.0, 11.1)
Numbness 72 (24) 15 (1) 6.7 (1.9, 23.1)
Pins and needles 1 (<1) 1 (<1) e
Other 9 (3) 45 (2) 1.3 (0.6, 3.1)
Knee swelling 149 (50) 668 (35) 14.5 (8.3, 25.4)
Limping 191 (64) 804 (42) 12.4 (7.4, 20.8)
Knee stiffness lasting >20 min 178 (60) 505 (26) 10.9 (7.0, 17.1)
Woken at night by knee pain 103 (35) 189 (10) 7.0 (4.3, 11.2)
Taking more medication than usual 94 (34) 181 (12) 23.9 (13.8, 41.4)
Pain stopped usual activities 44 (15) 76 (4) 26.5 (13.7, 51.5)
Figures are n (%) unless otherwise stated.
NRS Numerical rating scale; SD Standard deviation.
* Days during a flare-up (i.e., from start of flare-up to first day when pain returned to ‘normal’ levels for five consecutive days.
y Excludes flare-up days as well as the five consecutive days after last flare-up day.
z Frommixed-effect model (logistic for binary and linear for continuous outcome). Results are expressed as odds ratios (95% CI) except average knee pain intensity which is
expressed as a regression coefficient (i.e., mean difference) and 95% CI.
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small number reported stopping usual activities. Our study did not
capture lesser but still problematic interference with activities
whichmay affect quality of life if sustained.We recognise that there
may be potential time-varying confounders that could not be
controlled in the study, for example, those causing psychosocial
stress or a perceived improvement in symptoms, leading to a
reduction in medication and increase in activity.
Limitations of the study include the potential for inaccurate
recall of average pain scores over the 24-h period and the extent to
which participants may have retrospectively filled in diary entries.
We also acknowledge the bias that may be introduced by missing
data. Our case-crossover analysis was unable to explore individual
physical exposures due to small numbers and the use of ambidir-
ectional control windows assumes no strong effect of flare-ups on
subsequent exposure levels.
In providing an operational definition of a flare-up we recognise
the need for continued empirical work. Sensitivity analyses in
larger datasets could usefully explore whether absolute or relative
(to baseline) increases in pain are best for defining flare-ups as well
as the minimum duration of these.
Conclusion
Our study with intensive longitudinal data collection suggests
acute flare-ups may be experienced by a substantial number of
patients. These episodes often last a week or longer, are disruptive,
prompt changes in self-management, and may be triggered by
high-loading physical activities.
Author contributions
All authors were involved in conception and design of the study,
analysis and interpretation of data, drafting the article, critical
revision of the article for important intellectual content, final
approval of the article. GP takes responsibility for the integrity of
the work as a whole from inception to finished article.
Competing interest
GP received consultancy fees from InFirst plc and Good Relations plc.Role of the funding source
The paper presents research funded by Arthritis Research UK
[Centre of Excellence award: 18139]. ELP received funding from a
National Institute for Health Research (NIHR) In-Practice Fellow-
ship, NIHR Academic Clinical Fellowship and SPCR GP Progression
Fellowship.
The views expressed are those of the author(s) and not neces-
sarily those of the NHS, the NIHR or the Department of Health.Supplementary data
Supplementary data to this article can be found online at
https://doi.org/10.1016/j.joca.2019.04.003.References
1. Nicholls E, Thomas E, van der Windt DA, Croft PR, Peat G.
Pain trajectory groups in persons with, or at high risk of,
knee osteoarthritis: findings from the Knee Clinical Assess-
ment Study and the Osteoarthritis Initiative. Osteoarthritis
Cartilage 2014;22:2041e50, https://doi.org/10.1016/j.joca.
2014.09.026.
2. Murphy SL, Lyden AK, Kratz AL, Fritz H, Williams DA, Clauw DJ,
et al. Characterizing pain flares from the perspective of in-
dividuals with symptomatic knee osteoarthritis. Arthritis Care
Res 2015;67:1103e11, https://doi.org/10.1002/acr.22545.
3. Hawker GA, Stewart L, French MR, Cibere J, Jordan JM, March L,
et al. Understanding the pain experience in hip and
knee osteoarthritis e an OARSI/OMERACT initiative. Osteoar-
thritis Cartilage 2008;16:415e22, https://doi.org/10.1016/j.
joca.2007.12.017.
4. Ricci JA, Stewart WF, Chee E, Leotta C, Foley K, Hochberg MC.
Pain exacerbation as a major source of lost productive time in
US workers with arthritis. Arthritis Rheum 2005;53:673e81,
https://doi.org/10.1002/art.21453.
5. Marty M, Hilliquin P, Rozenberg S, Valat JP, Vignon E, Coste P,
et al. Validation of the KOFUS (knee osteoarthritis flare-ups
score). Joint Bone Spine 2009;76:268e72, https://doi.org/10.
1016/j.jbspin.2008.07.018.
E. Parry et al. / Osteoarthritis and Cartilage 27 (2019) 1124e112811286. Parry EL, Thomas MJ, Peat G. Defining acute flares in knee
osteoarthritis: a systematic review. BMJ Open 2018;8,
e019804, https://doi.org/10.1136/bmjopen-2017-019804.
7. Zobel I, Erfani T, Bennell KL, Makovey J, Metcalf B, Chen JS, et al.
Relationship of buckling and knee injury to pain exacerbation
in knee osteoarthritis: a web-based case-crossover study.
Interact J Med Res 2016;5:e17, https://doi.org/10.2196/
ijmr.5452.
8. Trappenburg JCA, Monninkhof EM, Bourbeau J, Troosters T,
Schrijvers AJP, Verheij TJM, et al. Effect of an action plan with
ongoing support by a case manager on exacerbation-related
outcome in patients with COPD: a multicentre randomised
controlled trial. Thorax 2011;66:977e84, https://doi.org/
10.1136/thoraxjnl-2011-200071.
9. Turk DC, Dworkin RH, Burke LB, Gershon R, Rothman M,
Scott J, et al. Developing patient-reported outcome measures
for pain clinical trials: IMMPACT recommendations. Pain
2006;125:208e15, https://doi.org/10.1016/j.pain.2006.09.028.
10. Dworkin RH, Turk DC, Revicki DA, Harding G, Coyne KS, Peirce-
Sandner S, et al. Development and initial validation of anexpanded and revised version of the Short-form McGill Pain
Questionnaire (SF-MPQ-2). Pain 2009;144:35e42, https://
doi.org/10.1016/j.pain.2009.02.007.
11. Cooper C, McAlindon T, Coggon D, Egger P, Dieppe P. Occu-
pational activity and osteoarthritis of the knee. AnnRheumDis
1994;53:90e3.
12. Harris RE, Williams DA, McLean SA, Sen A, Hufford M,
Gendreau RM, et al. Characterization and consequences of pain
variability in individuals with fibromyalgia. Arthritis Rheum
2005;52:3670e4, https://doi.org/10.1002/art.21407.
13. Burge S, Wedzicha JA. COPD exacerbations: definitions and
classifications. EurRespirJ 2003;21:46se53s.
14. Maclure M. The case-crossover design: a method for studying
transient effects on the risk of acute events. AmJEpidemiol
1991;133:144e53.
15. Schneider S, Junghaenel DU, Keefe FJ, Schwartz JE, Stone AA,
Broderick JE. Individual differences in the day-to-day vari-
ability of pain, fatigue, and well-being in patients with rheu-
matic disease: associations with psychological variables. Pain
2012;153:813e22, https://doi.org/10.1016/j.pain.2012.01.001.
